Approval · Notice of Compliance 37692 · 2026
IPG-RAMIPRIL: Notice of Compliance 37692
Issued June 10, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37692
- Date
- June 10, 2026
- Company
- Marcan Pharmaceuticals Inc.Ottawa, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to Product Monograph (to align with CRP approved PM). Removal of package insert. Update to package labels
- Canadian reference product
- ALTACE (Sanofi-Aventis Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IPG-RAMIPRIL | Not yet assigned | — |